Barclays’s LIPOSCIENCE INC COM LPDX Stock Holding History

Barclays’s Portfolio LPDX Stock Details LPDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-6,057	Closed	-$42K	–	7841
2013 Q2	$42K	Buy	+6,057	New	+$46.3K	﹤0.01%	6430

Other funds holding LPDX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

IPC

Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barclays's LPDX Position: Q3 2013 in Review

Barclays sold out of LIPOSCIENCE INC COM (LPDX) in Q3 2013, closing a stake of 6,057 shares — an estimated $42K sold.

Barclays first reported a position in LPDX in Q2 2013 and held it in 1 quarter. The position peaked at $42K in Q2 2013. 29 funds tracked by Wall St. Rank hold LPDX as of Q3 2013.

Barclays reported no remaining LIPOSCIENCE INC COM position as of Q3 2013 after selling out during the quarter.
Barclays sold 6,057 LIPOSCIENCE INC COM shares in Q3 2013, an estimated $42K.
Barclays first reported a position in LIPOSCIENCE INC COM in Q2 2013 and held it in 1 quarter.
Barclays's LIPOSCIENCE INC COM position peaked at $42K in Q2 2013.
29 funds tracked by Wall St. Rank held LIPOSCIENCE INC COM as of Q3 2013.

Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.